 0001682148-16-000001.txt : 20160815 0001682148-16-000001.hdr.sgml : 20160815 20160815170424 accession number:		0001682148-16-000001 conformed submission type:	sc 13d public document count:		2 filed as of date:		20160815 date as of change:		20160815 subject company:	 	company data:	 		company conformed name:			healthwarehouse.com, inc. 		central index key:			0000754813 		standard industrial classification:	retail-drug stores and proprietary stores [5912] 		irs number:				222413505 		state of incorporation:			de 		fiscal year end:			1231 	filing values: 		form type:		sc 13d 		sec act:		1934 act 		sec file number:	005-37321 		film number:		161833750 	business address:	 		street 1:		7107 industrial road 		city:			florence 		state:			ky 		zip:			41042 		business phone:		(513) 618-0911 	mail address:	 		street 1:		7107 industrial road 		city:			florence 		state:			ky 		zip:			41042 	former company:	 		former conformed name:	healthwarehouse, inc. 		date of name change:	20090818 	former company:	 		former conformed name:	clacendix, inc. 		date of name change:	20080107 	former company:	 		former conformed name:	ion networks inc 		date of name change:	19990413 filed by:		 	company data:	 		company conformed name:			reilly timothy e 		central index key:			0001682148 	filing values: 		form type:		sc 13d 	mail address:	 		street 1:		1085 gulf of mexico drive #602 		city:			longboat key 		state:			fl 		zip:			34228 sc 13d 1 sc-13d.htm schedule 13d sc-13d 10622618v1 united states securities and exchange commission washington, d.c. 20549 schedule 13d under the securities exchange act of 1934 (amendment no. )* healthwarehouse.com, inc. (name of issuer) common stock, $0.001 par value per share (title of class of securities) 42227g02 (cusip number) timothy e. reilly 1085 gulf of mexico drive #602 longboat key, florida 34228 (513) 703-5168 (name, address and telephone number of person authorized to receive notices and communications) july 28, 2016 (date of event which requires filing of this statement) if the filing person has previously filed a statement on schedule 13g to report the acquisition that is the subject of this schedule 13d, and is filing this schedule because of __240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. _ note: schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. see _240.13d-7 for other parties to whom copies are to be sent. * the remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. the information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of section 18 of the securities exchange act of 1934 ("act") or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act (however, see the notes). potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid omb control number. 10622618v1 cusip no. 42227g02 1. names of reporting persons. i.r.s. identification nos. of above persons (entities only). timothy e. reilly 2. check the appropriate box if a member of a group (see instructions) (a) _ (b) _ 3. sec use only 4. source of funds (see instructions) pf-oo 5. check if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) _ 6. citizenship or place of organization united states number of shares beneficially owned by each reporting person with 7. sole voting power 4,097,457 8. shared voting power none 9. sole dispositive power 4,097,457 10. shared dispositive power none 11. aggregate amount beneficially owned by each reporting person 4,097,457 12. check if the aggregate amount in row (11) excludes certain shares (see instructions) _ 13. percent of class represented by amount in row (11) 9.72 % 14. type of reporting person (see instructions) in 10622618v1 item 1. security and issuer. the class of equity securities to which this statement on schedule 13d (this "statement") relates are the shares of common stock, $0.001 par value per share (the "common shares"), of healthwarehouse.com, inc., a delaware corporation (the "company"). the principal executive offices of the company are located at 7107 industrial road, florence, kentucky 41042. item 2. identity and background. the name of the person filing this statement is timothy e. reilly, who is a citizen of the united states of america. timothy e. reilly holds shares of common stock directly and also owns shares of common stock through the following single-member ohio limited liability companies: melrose capital advisors, llc and dellave holdings llc. timothy e. reilly is sometimes referred to as the "reporting person." timothy e. reilly has his personal residence at 1085 gulf of mexico drive #602, longboat key, florida 34228. the reporting person's principal business is the managing member of the aforementioned limited liability companies, which are in principal business of personal investments and lending investment capital. during the last five years, the reporting persons has not been (i) convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors) or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. item 3. source and amount of funds or other consideration. on july 28, 2016, the company entered into and consummated the transactions contemplated by an exchange agreement (the "exchange agreement") with dellave holdings llc. pursuant to the exchange agreement, dellave holdings llc acquired 2,523,528 common shares in exchange for the extinguishment of certain accounts payable owed by the company to dellave holdings llc in the amount of $698,592.61. the reporting person acquired the additional common shares referenced in item 5 below via personal funds prior to the filing of this statement. the foregoing description of the exchange agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the exchange agreement, which are filed as exhibit 7.1 hereto, and is incorporated herein by reference. item 4. purpose of transaction. the reporting persons acquired the 4,097,457 common shares for investment purposes only with the goal of realizing the maximum value of such common shares. except as set forth in this statement, the reporting person does not have any plans or proposals which relate to or would result in: (a) the acquisition by any person of additional securities of the company, 10622618v1 or the disposition of securities of the company; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the company or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the company or any of its subsidiaries; (d) any change in the present board of directors or management of the company, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board of directors of the company; (e) any material change in the present capitalization or dividend policy of the company; (f) any other material change in the company's business or corporate structure, including but not limited to, if the company is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the investment company act of 1940, as amended; (g) changes in the company's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the company by any person; (h) causing a class of securities of the company to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the company becoming eligible for termination of registration pursuant to section 12(g)(4) of the securities exchange act of 1934, as amended (the "securities act"); or (j) any action similar to any of those enumerated above. the reporting person reserves the right to change its plans and intentions at any time, as it deems appropriate. item 5. interests in the securities of the purchaser. as of the date hereof, timothy e. reilly owns 4,097,457 common shares representing 9.72% of the issued and outstanding common shares. the calculations in this statement are based upon 42,160,786 common shares issued and outstanding as of august 5, 2016 (based upon the disclosure made by the company in its form 10-q for the quarter ended june 30, 2016). the reporting person's ownership consists of (i) 97,000 common shares attributable to timothy e. reilly's ira account, (ii) 1,173,103 common shares attributable to timothy e. reilly's cma account, (iii) 573,826 common shares owned by melrose capital advisors, llc in which timothy e. reilly is the sole member, and (iv) 2,523,528 common shares owned by dellave holdings llc in which 10622618v1 timothy e. reilly is the sole member. pursuant to an exchange agreement, dated july 28, 2016, dellave holdings llc acquired 2,523,528 common shares, at a per share price of $0.31, in exchange for the extinguishment of certain accounts payable in the amount of $698,592.61. no other transactions in the common shares have been effected by the reporting person in the past 60 days. item 6. contracts, arrangements, understandings or relationships with respect to securities of the issuer. the exchange agreement, which provided for the issuance of 2,253,528 common shares to the reporting person is described in item 3 of this statement above. the foregoing description of the exchange agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the exchange agreement, which is filed as exhibit 7.1, and is incorporated herein by reference. except as set forth in this statement, there are no contacts, arrangements, understandings or relationships (legal or otherwise) between the reporting person and any other person with respect to any of the securities of the company, including but not limited to, transfer or voting or any of the securities, finder's fees, joint ventures, loan or option arrangements, put or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies. item 7. material to be filed as exhibits. 7.1 exchange agreement, dated as of july 28, 2016, by and among the company and dellave holdings llc. signatures after reasonable inquiry and to the best of my knowledge and belief, i certify that the information set forth in this statement is true, complete and correct. dated: august 11, 2016 by: /s/ timothy e. reilly timothy e. reilly after reasonable inquiry and to the best of my knowledge and belief, i certify that the information set forth in this statement is true, complete and correct. ex-1 2 exhibit7.1.htm exchange agreement dellave exchange agreement share authorization exchange agreement this exchange agreement (the "agreement"), dated this 28th day of july 2016, is by and between healthwarehouse.com, inc. (the "company") and dellave holdings llc ("dellave"). the company and dellave are collectively referred to herein as the "parties." recitals whereas, dellave holds accounts payable that are liabilities of the company; whereas, the company's total current liabilities exceed the company's total assets, and at march 31, 2016 the company had a working capital deficiency of $4,260,215 and a total accumulated deficit of $31,498,616; whereas, the company's independent auditors indicated in their most recent audit opinion dated march 25, 2016 that there is substantial doubt about the company's ability to continue as a going concern in light of the company's significant losses in 2015 and 2014 and the company's need to raise additional funds to meet its obligations and sustain its operations; whereas, the company desires to have the accounts payable held by dellave extinguished in exchange for the issuance of shares of common stock of the company, par value $.001 per share ("company common stock"), which will result in a significant improvement in the company's balance sheet and financial health by reducing the company's current liabilities and increasing the company's stockholders' equity; whereas, the managing member of dellave is timothy e. reilly, and a separate company of mr. reilly is the senior lender to the company; whereas, dellave and mr. reilly are willing to exchange the accounts payable held by dellave for shares of company common stock in order to improve the company's ability to continue as a going concern and to have upside potential with respect to the company's common stock as the company's financial results and prospects improve; whereas, the company believes that it is the best interests of all of its stockholders to reduce its current liabilities in order to ensure the continued viability of the company; and whereas, the parties have agreed that it is in their mutual interests to enter into this agreement. now therefore, in consideration of the recitals and the representations, warranties, covenants and agreements contained herein and other good and valuable consideration, and intending to be legally bound hereby, the parties hereto agree as follows: 1.	representations and warranties of dellave. dellave represents and warrants to the company as follows: (a)	dellave holds as of the date of this agreement all rights and interest in and to each of the various accounts payable set forth in confidential exhibit 1 hereto, which accounts payable aggregate $698,593.61 as of the date hereof (the "accounts payable"); (b)	dellave has full power and authority to enter into and perform its obligations under this agreement, the execution and delivery of this agreement by dellave has been duly authorized, and the performance of the terms of this agreement will not constitute a violation of any limited partnership agreement, articles of incorporation, bylaws, operating agreement or any agreement or instrument to which dellave is a party; (c)	this agreement is a valid and binding obligation of dellave enforceable against dellave in accordance with its terms, subject to bankruptcy, insolvency and other laws affecting creditors' rights and general equitable principles; and (d)	there are no arrangements, agreements or understandings concerning the subject matter of this agreement between dellave and mr. reilly on the one hand and the company on the other hand, other than as set forth in this agreement. 	2.	representations and warranties of the company. (a)	the company hereby represents and warrants to dellave that the company has full power and authority to enter into and perform its obligations under this agreement and that the execution and delivery of this agreement by the company has been duly authorized by the board of directors of the company. this agreement constitutes a valid and binding obligation of the company and the performance of its terms will not constitute a violation of its certificate of incorporation or bylaws or any agreement or instrument to which the company is a party; and (b)	the company hereby represents and warrants to dellave that there are no arrangements, agreements or understandings concerning the subject matter of this agreement between the company on the one hand and dellave and mr. reilly on the other hand, other than as set forth in this agreement. 	3.	exchange of accounts payable for company common stock. (a)	effective as of the date of this agreement, dellave agrees that all of the accounts payable shall be extinguished in exchange for the company's issuance to dellave of 2,253,528 shares of company common stock, which shares were valued at $0.31 per share. dellave agrees that it shall have no further rights or interests in or to any of the accounts payable, and that all rights to collect payments from the company with respect to each of the accounts payable is hereby extinguished. (b)	the company agrees to provide timely instructions to its transfer agent to cause 2,523,528 shares of company common stock to be issued to dellave as of the date of this agreement. dellave acknowledges and agrees that the stock certificate for such shares of company common stock shall bear a restrictive legend which will read as follows: neither the issuance nor sale of the securities represented by this certificate has been registered under the securities act of 1933, as amended, or applicable state securities laws. the securities may not be offered for sale, sold, transferred or assigned (i) in the absence of (a) an effective registration statement for the securities under the securities act of 1933, as amended, or (b) an opinion of counsel, in a form reasonably acceptable to the company, that registration is not required under said act or (ii) unless sold pursuant to rule 144 or rule 144a under said act. notwithstanding the foregoing, the securities may be pledged in connection with a bona fide margin account or other loan or financing arrangement secured by the securities. 2 4.	covenants. (a)	dellave shall timey file a schedule 13d with the securities and exchange commission (the "sec")	to report its acquisition and beneficial ownership of the 2,523,528 shares of company common stock being issued pursuant to this agreement. (b)	the company shall timely file a current report on form 8-k with the sec to report its entry into this agreement. 5.	governing law and choice of forum. unless applicable delaware law or regulation is deemed controlling, kentucky law shall govern the construction and enforceability of this agreement. any and all actions concerning any dispute arising hereunder shall be filed and maintained in the united states district court for the eastern district of kentucky or, if there is no basis for federal jurisdiction, in the applicable state court of kentucky. each party agrees that the united states district court for the eastern district of kentucky may exercise personal jurisdiction over them in any such actions. 6.	severability. if any term or provision of this agreement is held by any governmental authority or a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms and provisions of this agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated. 7.	successors and assigns. this agreement shall be binding upon and shall inure to the benefit of and be enforceable by the successors and assigns, and transferees by operation of law, of the parties. except as otherwise expressly provided, this agreement shall not inure to the benefit of, be enforceable by or create any right or cause of action in any person, including any stockholder of the company, other than the parties to the agreement. 8.	survival of representations, warranties and covenants. all representations, warranties and covenants shall survive the execution and delivery of this agreement unless otherwise provided. 9.	amendments. this agreement may not be modified, amended, altered or supplemented except by a written agreement executed by all of the parties. 10.	counterparts; facsimile. this agreement may be executed in any number of counterparts and by the parties in separate counterparts, and signature pages may be delivered by facsimile or electronic delivery, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. [remainder of this page intentionally left blank.] 3 in witness whereof, this agreement has been duly executed by the undersigned and is effective as of the day and year first written above. healthwarehouse.com, inc. lalit	adphale chairman, president and chief executive officer dellave holdings, llc by: 	timothy e. reilly managing partner l:\42168\exchagne agreement-g28.docx 